Psoriatic arthritis affected 1.07 million people in the United States in 2004, according to a Frost & Sullivan report of North American primary care physicians and dermatologists.
The 2005 report “North American Psoriasis and Psoriatic Arthritis Markets” (www.frost.com) estimated that the number of people afflicted with psoriatic arthritis in this country is expected to grow to 1.15 million by 2011.
Yet, the report also noted that psoriatic arthritis is an underdiagnosed and undertreated condition — a finding that’s supported by physicians we interviewed for this month’s cover story “Who Should Manage Psoriatic Arthritis?”.
In the Frost & Sullivan report it was noted that in 2004 only 40% of psoriatic arthritis cases were diagnosed — or 0.52 million people. Of those, 66% were treated — or 0.35 million people.
The low diagnosed rate for psoriatic arthritis, according to the report, was due to the difficulty in diagnosing the condition since no definitive marker existed for identifying psoriatic arthritis.
Who is treating psoriatic arthritis patients?
Of the population of patients diagnosed with psoriatic arthritis, it’s interesting to note who is providing the treatment.
In the Frost & Sullivan report, primary care physicians and dermatologists indicated whether they treated psoriatic arthritis, referred them to a rheumatologist or both treated some patients and referred others.
In the report, 39% of respondents said they assumed treatment for these patients. An additional 44% did not treat these patients but instead referred them to a rheumatologist. Another 11% both treated and referred patients, and approximately 6% of the physicians interviewed had no cases of psoriatic arthritis.
This month’s cover story gives additional insight into different levels of this disease that dermatologists are treating, and what decision-making tools they’re using to determine when to refer cases.
Read their experiences so that you might gain a better perspective on managing or co-managing your psoriatic arthritis patients. Our story begins on page 34.
Larisa Hubbs
Executive Editor
lhubbs@hmpcommunications.com
Psoriatic arthritis affected 1.07 million people in the United States in 2004, according to a Frost & Sullivan report of North American primary care physicians and dermatologists.
The 2005 report “North American Psoriasis and Psoriatic Arthritis Markets” (www.frost.com) estimated that the number of people afflicted with psoriatic arthritis in this country is expected to grow to 1.15 million by 2011.
Yet, the report also noted that psoriatic arthritis is an underdiagnosed and undertreated condition — a finding that’s supported by physicians we interviewed for this month’s cover story “Who Should Manage Psoriatic Arthritis?”.
In the Frost & Sullivan report it was noted that in 2004 only 40% of psoriatic arthritis cases were diagnosed — or 0.52 million people. Of those, 66% were treated — or 0.35 million people.
The low diagnosed rate for psoriatic arthritis, according to the report, was due to the difficulty in diagnosing the condition since no definitive marker existed for identifying psoriatic arthritis.
Who is treating psoriatic arthritis patients?
Of the population of patients diagnosed with psoriatic arthritis, it’s interesting to note who is providing the treatment.
In the Frost & Sullivan report, primary care physicians and dermatologists indicated whether they treated psoriatic arthritis, referred them to a rheumatologist or both treated some patients and referred others.
In the report, 39% of respondents said they assumed treatment for these patients. An additional 44% did not treat these patients but instead referred them to a rheumatologist. Another 11% both treated and referred patients, and approximately 6% of the physicians interviewed had no cases of psoriatic arthritis.
This month’s cover story gives additional insight into different levels of this disease that dermatologists are treating, and what decision-making tools they’re using to determine when to refer cases.
Read their experiences so that you might gain a better perspective on managing or co-managing your psoriatic arthritis patients. Our story begins on page 34.
Larisa Hubbs
Executive Editor
lhubbs@hmpcommunications.com
Psoriatic arthritis affected 1.07 million people in the United States in 2004, according to a Frost & Sullivan report of North American primary care physicians and dermatologists.
The 2005 report “North American Psoriasis and Psoriatic Arthritis Markets” (www.frost.com) estimated that the number of people afflicted with psoriatic arthritis in this country is expected to grow to 1.15 million by 2011.
Yet, the report also noted that psoriatic arthritis is an underdiagnosed and undertreated condition — a finding that’s supported by physicians we interviewed for this month’s cover story “Who Should Manage Psoriatic Arthritis?”.
In the Frost & Sullivan report it was noted that in 2004 only 40% of psoriatic arthritis cases were diagnosed — or 0.52 million people. Of those, 66% were treated — or 0.35 million people.
The low diagnosed rate for psoriatic arthritis, according to the report, was due to the difficulty in diagnosing the condition since no definitive marker existed for identifying psoriatic arthritis.
Who is treating psoriatic arthritis patients?
Of the population of patients diagnosed with psoriatic arthritis, it’s interesting to note who is providing the treatment.
In the Frost & Sullivan report, primary care physicians and dermatologists indicated whether they treated psoriatic arthritis, referred them to a rheumatologist or both treated some patients and referred others.
In the report, 39% of respondents said they assumed treatment for these patients. An additional 44% did not treat these patients but instead referred them to a rheumatologist. Another 11% both treated and referred patients, and approximately 6% of the physicians interviewed had no cases of psoriatic arthritis.
This month’s cover story gives additional insight into different levels of this disease that dermatologists are treating, and what decision-making tools they’re using to determine when to refer cases.
Read their experiences so that you might gain a better perspective on managing or co-managing your psoriatic arthritis patients. Our story begins on page 34.
Larisa Hubbs
Executive Editor
lhubbs@hmpcommunications.com
